Note J - Derivatives and Hedging

9 Months Ended

Mar. 31, 2018

Notes to Financial Statements

Derivative Instruments and Hedging Activities Disclosure [Text Block]

J. Derivatives and Hedging

We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales and other transactions of NAIE, our foreign subsidiary denominated in foreign currencies. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we sometimes use foreign exchange contracts in the form of forward contracts. To the extent we enter into such contracts, there can be

no

guarantee any such contracts will be effective hedges against our foreign currency exchange risk.

As of

March 31, 2018,

we had forward contracts designated as cash flow hedges primarily to protect against the foreign exchange risks inherent in our forecasted sales of products at prices denominated in currencies other than the U.S. Dollar. These contracts are expected to be settled through

August 2019.

For derivative instruments that are designated and qualify as cash flow hedges, we record the effective portion of the gain or loss on the derivative in other comprehensive income (loss) as a separate component of stockholders’ equity and subsequently reclassify these amounts into earnings in the period during which the hedged transaction is recognized in earnings.

For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as interest expense or income. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. We did

not

have any losses or gains related to the ineffective portion of our hedging instruments during the

three

and

nine

months ended

March 31, 2018.

During the

three

months ended

March 31, 2017,

we recorded a

$97,000

gain related to the ineffective portion of our hedging instruments to other income. During the

nine

months ended

March 31, 2017,

we recorded a

$189,000

gain related to the ineffective portion of our hedging instruments to other income.

None

of our foreign currency forward contracts were terminated as a result of ineffective hedging or as a result of forecasted transactions

no

longer probable of occurring for foreign currency forward contracts. We monitor the probability of forecasted transactions as part of our hedge effectiveness testing on a quarterly basis.

As of

March 31, 2018,

the notional amounts of our foreign exchange contracts designated as cash flow hedges were approximately

$47.1

million (EUR

40.0

million). As of

March 31, 2018,

a net loss of approximately

$2.9

million related to derivative instruments designated as cash flow hedges was recorded in OCI. It is expected that

$2.4

million will be reclassified into earnings in the next

12

months along with the earnings effects of the related forecasted transactions.

As of

March 31, 2018,

the fair value of our cash flow hedges was a liability of

$3.1

million, of which

$2.6

million was classified as a current liability, and

$480,000

was classified in other noncurrent liabilities in our Consolidated Balance Sheets. During the

three

months ended

March 31, 2018,

we recognized

$1.2

million of net losses in OCI and reclassified

$974,000

of losses from OCI to revenue. During the

nine

months ended

March 31, 2018,

we recognized

$4.1

million of net losses in OCI and reclassified

$1.8

million of losses from OCI to revenue. As of

June 

30,

2017,

$422,000

of the fair value of our cash flow hedges was classified in accrued liabilities, and

$99,000

was classified other noncurrent liabilities in our Consolidated Balance Sheets. During the

three

months ended

March 31, 2017,

we recognized

$322,000

of losses in OCI and reclassified

$278,000

of gains from OCI to revenue. During the

nine

months ended

March 31, 2017,

we recognized

$1.5

million of net gains in OCI and reclassified

$549,000

of gains from OCI to revenue.